CTL-06
CTL-06 is an inhibitor of Fatty Acid Synthase (FASN) (IC50: 3 μM) and can induce apoptosis. CTL-12 blocks the cell cycle in the Sub-G1/S phase, upregulates the expression of caspase-9 and the apoptosis marker Bax, and downregulates the anti-apoptotic marker Bcl-xL. CTL-12 inhibits de novo lipogenesis, blocks the metabolic demands of tumor cells, and is commonly used in breast and colorectal cancer research[1].
Product Specifications
UNSPSC
12352005
Target
Fatty Acid Synthase (FASN)
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/ctl-06.html
Solubility
10 mM in DMSO
Smiles
O=C(C1=CC=C2C(N=C(C3=C(O)C=CC(Cl)=C3)N2)=C1)N4CCN(C(OCC)=O)CC4
Molecular Formula
C21H21ClN4O4
Molecular Weight
428.87
References & Citations
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Mouse Probable G-protein coupled receptor 113, GPR113 ELISA Kit
Mouse Probable G-protein coupled receptor 113, GPR113 ELISA Kit
Mouse Probable G-protein coupled receptor 113, GPR113 ELISA Kit
Mouse Probable G-protein coupled receptor 113, GPR113 ELISA Kit
MRPL1 (39S Ribosomal Protein L1, Mitochondrial, L1mt, MRP-L1, BM-022, FLJ96680) (AP) discontinued
